ModelEdge

Aerie Pharmaceuticals Inc
0001337553
Filing Type8-K
Filing Date11/20/2022
Updated11/21/22, 3:01 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1EXHIBIT 3.1
EX-3.2EXHIBIT 3.2
EX-4.1EXHIBIT 4.1